Boston Medical Center

Running trials

• Not yet recruiting

  Anti-Interleukin-6 (IL6) in Calciphylaxis

  NCT07708038· Phase 1· Source

• Not yet recruiting

  Boston Medical Center Ultrasound Decongestion Study in Heart Failure

  NCT07096726· Source

• Not yet recruiting

  Cilostazol for Prevention of Recurrent Stroke Trial

  NCT07174414· Phase 3· Source

• Recruiting

  A Randomized Placebo-procedure Controlled Trial of the Enhancor System (PULmonary Artery Denervation) to Evaluate Safety and Efficacy in Patients With Combined Pre- and Post-capillary Pulmonary Hypertension Associated With Left Heart Disease

  NCT07214376· Source

• Recruiting

  Longitudinal Study of Retinal Function in Eyes Treated for Diabetic Macular Edema With Anti-VEGF Agents

  NCT07567833· Phase 4· Source

• Recruiting

  Study of GS-0415 and How It Works in People With HIV

  NCT07719491· Phase 1· Source

• Recruiting

  A US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptoms Despite Taking Parkinson's Medications

  NCT07330258· Source

• Recruiting

  Behavior Analytic Support of Needle-related Hospital Visits for Autistic Patients

  NCT06712784· Source

• Recruiting

  EncompaSSc: Evaluation of MTX-474 in Participants With Diffuse Cutaneous Systemic Sclerosis (dcSSc)

  NCT07287670· Phase 2· Source

• Recruiting

  A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes

  NCT07351045· Phase 3· Source

• Recruiting

  Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD)

  NCT07224360· Phase 2· Source

• Recruiting

  A Study of JNJ-90301900 in Combination With Chemoradiation Therapy in Participants With Locally Advanced Head and Neck Squamous Cell Carcinoma

  NCT07219212· Phase 1· Source

• Enrolling by invitation

  SafeHeal Colovac Anastomosis Protection Device Evaluation Pivotal Study

  NCT07116668· Source

• Recruiting

  Improving Diabetes Care With Strategies For Addressing Health-Related Social Needs and Community Partnerships

  NCT07043426· Source

• Recruiting

  Teclistamab-Daratumumab in AL Amyloidosis

  NCT07110844· Phase 2· Source

• Recruiting

  Evaluation of Treatment Satisfaction and KarXT Utilization Registry (RESKU)

  NCT07101094· Source

• Recruiting

  US Benchmarking Clinical Study

  NCT07215715· Source

• Recruiting

  Improving Hypertension Control in Safety-Net Settings: The Boston Hypertension Equity Alliance in Treatment

  NCT06948838· Source

• Recruiting

  Faricimab + PRP vs. Vitrectomy + Endolaser for Treatment of PDR

  NCT06790784· Phase 3· Source

• Recruiting

  Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer

  NCT06532279· Phase 2· Source

• Recruiting

  Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment

  NCT06589804· Phase 3· Source

• Recruiting

  A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2)

  NCT06615479· Phase 3· Source

• Recruiting

  A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease

  NCT06925542· Phase 1· Source

• Recruiting

  Alleviant ALLAY-HFrEF Study

  NCT06812533· Source

• Recruiting

  Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL

  NCT06806033· Phase 2· Source

• Recruiting

  Hybrid Closed Loop Effectiveness Trial in Adults With Type 1 Diabetes

  NCT06236607· Source

• Recruiting

  A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease

  NCT06612268· Phase 3· Source

• Recruiting

  StrokeNet Thrombectomy Endovascular Platform

  NCT06289985· Source

• Recruiting

  A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia

  NCT06609226· Phase 3· Source

• Recruiting

  A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

  NCT06588478· Phase 2· Source

• Recruiting

  A Study of Toripalimab in Combination With Cisplatin and Gemcitabine in Participants With Recurrent Metastatic Nasopharyngeal Cancer

  NCT06457503· Phase 4· Source

• Active, not recruiting

  Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Diffuse Cutaneous Systemic Sclerosis

  NCT06655896· Phase 2· Source

• Recruiting

  LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis

  NCT06632444· Phase 3· Source

• Recruiting

  Non-Invasive Monitoring Methods in Patients With Acute Brain Injury

  NCT06504238· Source

• Recruiting

  Safety and Effectiveness of Mechanical Thrombectomy Using the Anaconda ANA Funnel Catheter

  NCT06370182· Source

• Active, not recruiting

  A Study of Rapcabtagene Autoleucel in Active, Refractory Systemic Lupus Erythematosus (SLE) or Lupus Nephritis (LN) Patients (AUTOGRAPH - SLE/LN)

  NCT06581198· Phase 2· Source

• Active, not recruiting

  A Study Comparing Anitocabtagene Autoleucel to Standard of Care Therapy in Participants With Relapsed/ Refractory Multiple Myeloma

  NCT06413498· Phase 3· Source

• Recruiting

  A Trial to Learn if Linvoseltamab is Safe and Works in Adults With Relapsed or Refractory Systemic Light Chain Amyloidosis (AL Amyloidosis)

  NCT06292780· Phase 1/2· Source

• Enrolling by invitation

  Improving Outcomes and Reducing Disparities for Patients With Inflammatory Bowel Disease Through Epidemiology and Enhanced Disease Management

  NCT06424769· Source

• Recruiting

  A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease

  NCT06481306· Phase 1/2· Source

• Recruiting

  Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagnosed AL Amyloidosis

  NCT06022939· Phase 3· Source

• Recruiting

  A Mobile Gaming App to Improve Adherence to PrEP

  NCT05762705· Source

• Recruiting

  Proximal Internal Carotid Artery Acute Stroke Secondary to Tandem or Local Occlusion Thrombectomy Trial

  NCT05611242· Phase 3· Source

• Recruiting

  A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Immunoglobulin Light Chain (AL) Amyloidosis Receiving Etentamig (ABBV-383) as an Intravenous (IV) Infusion

  NCT06158854· Phase 1/2· Source

• Recruiting

  Maturation of Arteriovenous Fistula With Automated Sonography Assessments Trial

  NCT06190717· Source

• Active, not recruiting

  A Study of SGN-B6A Versus Docetaxel in Previously Treated Non-small Cell Lung Cancer

  NCT06012435· Phase 3· Source

• Recruiting

  A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

  NCT06119581· Phase 3· Source

• Recruiting

  PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III

  NCT05934487· Source

• Recruiting

  Treatment With Endovascular Intervention for STroke Patients With Existing Disability

  NCT05911568· Source

• Active, not recruiting

  A Study of the Efficacy and Safety of Adjuvant Autogene Cevumeran Plus Atezolizumab and mFOLFIRINOX Versus mFOLFIRINOX Alone in Participants With Resected PDAC

  NCT05968326· Phase 2· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Stroke11 recruiting
• Amyloidosis6 recruiting
• Heart failure6 recruiting
• Chronic kidney disease4 recruiting
• Head and neck cancer4 recruiting
• Lung cancer3 recruiting
• Sickle cell disease3 recruiting
• Atrial fibrillation2 recruiting
• Colorectal cancer2 recruiting
• Coronary artery disease2 recruiting
• Diabetic eye disease2 recruiting
• High blood pressure2 recruiting
• HIV2 recruiting
• Multiple myeloma2 recruiting
• Systemic sclerosis (scleroderma)2 recruiting
• Triple-negative breast cancer2 recruiting
• Type 1 diabetes2 recruiting
• Type 2 diabetes2 recruiting
• Autism1 recruiting
• Childhood cancers1 recruiting
• Chronic lymphocytic leukaemia1 recruiting
• Crohn's disease1 recruiting
• Diffuse large B-cell lymphoma1 recruiting
• Fatty liver disease (MASLD/MASH)1 recruiting
• Follicular lymphoma1 recruiting
• Gastric and esophageal cancer1 recruiting
• Hodgkin lymphoma1 recruiting
• Hypertrophic cardiomyopathy1 recruiting
• Lupus (SLE)1 recruiting
• Obesity1 recruiting
• Parkinson disease1 recruiting
• Pulmonary arterial hypertension1 recruiting
• Schizophrenia1 recruiting
• Ulcerative colitis1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Terminated

  Open-Label Extension Study to Pioneer Study 6058-SCD-101

  NCT07401823· Phase 2· Source

• Completed

  Innovative Automated Insulin Delivery System for Type 2 Diabetes

  NCT06853990· Source

• Recruiting

  A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populations With Advanced, Previously Treated Colorectal Cancer

  NCT06562543· Phase 4· Source

• Terminated

  Conversational Agents to Improve HPV Vaccine Acceptance in Primary Care (ECA-HPV)- Clinical Trial

  NCT06367699· Source

• Completed

  RECOVER-SLEEP: Platform Protocol

  NCT06404086· Phase 2· Source

• Completed

  A Novel Social Emotional Learning Curriculum for Youth With Epilepsy

  NCT06427967· Source

• Withdrawn

  Lactobacillus Lozenges as Preventative Care in Low-grade Dysplasia

  NCT05707702· Phase 3· Source

• Completed

  SafeHeal Diverting Ileostomy Pivotal Study

  NCT06152276· Source

• Withdrawn

  Mobile Application to Create Healthy Food Preparation Habits for Patients With Diabetes and Prediabetes

  NCT05726409· Source

• Completed

  RECOVER-NEURO: Platform Protocol to Measure the Effects of Cognitive Dysfunction Interventions on Long COVID Symptoms

  NCT05965752· Source

• Completed

  Refinement and Adaption of Reinforcement Learning to Personalize Behavioral Messaging for Healthy Habits

  NCT05742685· Source

• Completed

  RECOVER-VITAL: Platform Protocol to Measure the Effects of Antiviral Therapies on Long COVID Symptoms

  NCT05595369· Phase 2· Source

• Completed

  INHALE-3: Afrezza® Combined With Insulin Degludec Versus Usual Care in Adults With Type 1 Diabetes

  NCT05904743· Phase 4· Source

• Completed

  A Randomized Trial Evaluating Control-IQ+ Technology in Adults With Type 2 Diabetes

  NCT05785832· Source

• Terminated

  A Study of NUC-3373 in Combination With Other Agents in Patients With Colorectal Cancer

  NCT05678257· Phase 2· Source

• Completed

  Transitioning Together Boston

  NCT05599711· Source

• Terminated

  A Study of LY3540378 in Participants With Worsening Chronic Heart Failure With Preserved Ejection Fraction (HFpEF)

  NCT05592275· Phase 2· Source

• Terminated

  Total Joint Arthroplasty (TJA) Weight Loss Study

  NCT05156762· Source

• Completed

  Study of Pembrolizumab/Vibostolimab (MK-7684A) in Combination With Concurrent Chemoradiotherapy Followed by Pembrolizumab/Vibostolimab Versus Concurrent Chemoradiotherapy Followed by Durvalumab in Participants With Stage III Non-small Cell Lung Cancer (MK-7684A-006)

  NCT05298423· Phase 3· Source

• Completed

  Tuberculosis - Learning the Effect of Parasites and Reinforcing Diets

  NCT05048485· Source

• Completed

  A Prospective and Retrospective Observational Study of Multidrug-Resistant Patient Outcomes With and Without Ibalizumab

  NCT05388474· Source

• Completed

  A Randomized, Controlled Trial to Evaluate the Safety and Effectiveness of the Route 92 Medical Reperfusion System (SUMMIT MAX)

  NCT05018650· Source

• Completed

  Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Pociredir

  NCT05169580· Phase 1· Source

• Completed

  Digital Health Weight Management Among Public Housing Residents

  NCT04852042· Source

• Completed

  Pilot Study of Biopsy Scanner for Evaluation of Bronchoscopic Small Biopsy Specimens to Determine Adequacy

  NCT05393154· Source

• Completed

  Improving Medical Decision Making for Older Patients With End Stage Renal Disease

  NCT04347629· Source

• Completed

  Synuclein-One Study

  NCT04700722· Source

• Completed

  A Research Study to Compare a Medicine Called Semaglutide Against Placebo in People With Peripheral Arterial Disease and Type 2 Diabetes

  NCT04560998· Phase 3· Source

• Completed

  Lenvatinib (E7080/MK-7902) in Combination With Pembrolizumab (MK-3475) vs. Standard Chemotherapy and Lenvatinib Monotherapy in Participants With Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma That Progressed After Platinum Therapy and Immunotherapy (MK-7902-009/E7080-G000-228/LEAP-009)

  NCT04428151· Phase 2· Source

• Completed

  A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AG-946 in Healthy Volunteers and in Participants With Sickle Cell Disease

  NCT04536792· Phase 1· Source

• Completed

  Sickle Cell Disease and CardiovAscular Risk - Red Cell Exchange Trial (SCD-CARRE)

  NCT04084080· Phase 3· Source

• Completed

  Cabozantinib and Nivolumab for Carcinoid Tumors

  NCT04197310· Phase 2· Source

• Completed

  A Mobile Gaming App to Improve ART Adherence for Youth

  NCT03760211· Source

• Completed

  A Study of Tepotinib Plus Osimertinib in Osimertinib Relapsed MET Amplified NSCLC (INSIGHT 2)

  NCT03940703· Phase 2· Source

• Completed

  Autism Adaptive Community-based Treatment to Improve Outcomes Using Navigators (ACTION) Network

  NCT03575429· Source

• Terminated

  Shingrix Vaccine in Patients With Moderate to Severe Ulcerative Colitis on Tofacitinib

  NCT03591770· Phase 4· Source

• Completed

  Safety and Efficacy of Pembrolizumab (MK-3475) Versus Placebo as Adjuvant Therapy in Participants With Hepatocellular Carcinoma (HCC) and Complete Radiological Response After Surgical Resection or Local Ablation (MK-3475-937 / KEYNOTE-937)

  NCT03867084· Phase 3· Source

• Completed

  Phase 3 Trial of Elacestrant Versus Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer

  NCT03778931· Phase 3· Source

• Completed

  BV-CHEP Chemotherapy for Adult T-cell Leukemia or Lymphoma

  NCT03264131· Phase 2· Source

• Completed

  VGX-3100 and Electroporation in Treating Patients With HIV-Positive High-Grade Anal Lesions

  NCT03603808· Phase 2· Source

• Completed

  Duvelisib and Venetoclax in Relapsed or Refractory CLL or SLL or RS

  NCT03534323· Phase 1/2· Source

• Completed

  Cisplatin/Carboplatin and Etoposide With or Without Nivolumab in Treating Patients With Extensive Stage Small Cell Lung Cancer

  NCT03382561· Phase 2· Source

• Completed

  Radiation Therapy With Durvalumab or Cetuximab in Treating Patients With Locoregionally Advanced Head and Neck Cancer Who Cannot Take Cisplatin

  NCT03258554· Phase 2/3· Source

• Completed

  ThRombectomy In Mild Ischemic Stroke With a Visible Intracranial veSsel Occlusion

  NCT06778226· Source

• Completed

  Risk Factors and Outcomes of Ischemic Stroke Associated With Tandem or Isolated Cervical Artery Occlusion in Anterior and Posterior Circulation

  NCT06965036· Source

• Completed

  An Investigational Immunotherapy Study of Nivolumab in Combination With Rucaparib, Docetaxel, or Enzalutamide in Metastatic Castration-resistant Prostate Cancer

  NCT03338790· Phase 2· Source

• Completed

  Adolescent Master Protocol for Participants 18 Years of Age or Older - Lite

  NCT03279185· Source

• Terminated

  A Study of Modakafusp Alfa on Adult Participants With Relapsed/Refractory Multiple Myeloma

  NCT03215030· Phase 1/2· Source

• Completed

  Hypofractionated Radiation Therapy or Conventional Radiation Therapy After Surgery in Treating Patients With Prostate Cancer

  NCT03274687· Phase 3· Source

• Completed

  Impact of Smoking and Its Cessation on Systemic and Airway Immune Activation

  NCT02836067· Source

Trial sites

• Boston Med Ctr1 trial
• Boston Medical Center197 trials
• Boston Medical Center (BMC) - Cancer Care Center1 trial
• Boston Medical Center_Boston_11 trial
• Boston Medical Center_Cary3 trials
• Boston Medical Center Corporation7 trials
• Boston Medical Center - Dept. Hematology/Oncology1 trial
• Boston Medical Center, General Internal Medicine primary care1 trial
• Boston Medical Center /ID# 2236061 trial
• Boston Medical Center /ID# 2550661 trial
• Boston Medical Center, Neurology and remote1 trial
• Boston Medical Center (Site 0025)1 trial
• Boston Medical Center (Site 0057)1 trial
• Boston Medical Center (Site 1605)1 trial
• Boston Medical Center (Site 2829)1 trial

Conditions

Diseases this institution publishes on or runs trials for.

• Stroke235 works · 16 trials
• HIV80 works · 13 trials
• Atrial fibrillation67 works · 3 trials
• Chronic kidney disease52 works · 6 trials
• Amyloidosis47 works · 8 trials
• Tuberculosis45 works · 1 trials
• Sickle cell disease13 works · 10 trials
• Chronic lymphocytic leukaemia6 works · 3 trials
• Mantle cell lymphoma4 works · 0 trials